Instem at ACT Annual Meeting, 2023
Instem, Booth 212
Discover our innovative Study Management, Regulatory & In Silico Solutions
Provantis®
As the #1 preclinical software suite for organizations engaged in non-clinical evaluation studies, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within both GLP and non-GLP environments.
Learn more about our new standalone modules within our Pathology suite, including modules for Tissues Processing, Image Management, and Spotlighter™ , our historical data solution that helps you find the hidden value in your reference data.
SEND Solutions
The most comprehensive and widely deployed set of software (submit™) and services (SEND Advantage™) supporting the creation and management of SEND datasets. Stop by our booth to learn more about our two NEW software solutions, DefineNow™ for the creation and editing of define.xml files and GuidePro™, Instem’s Study Data Reviewer’s Guide generator.
Genetic Toxicology
Image analysis and data management solutions helping users better collect, manage, review and extract data while transitioning information into insight, utilizing our Comet Assay IV and Cyto Study Manager tools. Also, don’t miss the opportunity to learn more about our new Transgenic Rodent Assay module!
(NEW) Advance™ Weight of Evidence Assessments: Instem’s latest In Silico service which is re-imagining the way organizations perform carcinogenicity assessments via the 6 Weight of Evidence (WoE) factors under the ICH S1B guideline.
KnowledgeScan™ Target Safety Assessment (TSA) Service: Delivering comprehensive TSAs for clients around the world, enabling them to make faster, better-informed decisions on their drug targets.
Watch the KnowledgeScan Explainer video
Leadscope Model Applier™: Advanced informatics and prediction technology, together with comprehensive database solutions that are helping organizations effectively unlock valuable knowledge contained in both public and proprietary sources of research data. Ask about our new module Leadscope N-nitrosamine CPCA.
Predict™ In Silico Toxicology service: A leading edge, technology-enabled service that delivers a combination of powerful computation models with expert scientific review, to help clients predict chemical safety more quickly, efficiently and comprehensively.
Centrus®: An innovative technology platform that delivers a combination of pioneering, well-integrated computing modules, along with a comprehensive catalogue of non-clinical and clinical data.
If you would like to schedule a discussion with us during ACT contact us at info@instem.com indicating your area of interest.
Instem Event Schedule
Tuesday, November 14
Exhibitor Hosted Event: Using Translational Science Tools to Support an Integrated Weight of Evidence Approach: Case Study on ICH S1B Carcinogenicity Assessment.
Tuesday, November 14, 12:00 PM - 12:55 PM (EST), Room E5
We will present the latest intelligence surrounding translational safety assessment, including an illustration of the recently revised ICH S1B guideline. A demonstration of how clinical and preclinical data, together with evidence from literature and database searches, can be collated and reviewed in a defined workflow, then extrapolated to gain scientific insight.
Presented by: Frances Hall, PhD, Senior Director, In Silico Solutions, Instem and Brenda Finney, PhD, Vice President, In Silico & Translational Science, Instem
Lunch will be provided
Wednesday, November 15
Symposium Gold Sponsor of ACT Session number S15, Managing Nitrosamine Impurities in Pharmaceuticals: 2023 Update
Wednesday, November 15, 9 AM - 12.00 PM (EST)
Symposium Presentation: Factors Influencing the Potency of N-Nitrosamines: Reviewing the Carcinogenic Potency Categorization Approach
Presented by: Kevin Cross, PhD, VP of Regulatory Science
We are also pleased to be involved in the following posters:
Abstract Title: Translational and in silico assessment of liver injury for 4-hydroxy-2,6-dichlorodiphenylamine.
Presenting Author: Brenda Finney, PhD, Vice President, In Silico & Translational Science, Instem
Poster Session Date and Time: Monday, November 13, 5.00 PM – 6.30 PM (EST)
Abstract Title: Standardized Target Carcinogenicity Assessment (TCA) Enables ICH S1B-based Regulatory Decisions
Presenting Author: Frances Hall, PhD, Senior Director, In Silico Solutions, Instem
Poster Session Date and Time: Monday, November 13, 5.00 PM – 6.30 PM (EST)
Poster Number: 205
Instem are participating in the ACT ToxHunt game so stop by our booth 212 to scan a QR code that will earn you points.